About Motaz Qadan, MD, PhD

Watch a video about my work

Motaz Qadan, MD, PhD, is a surgical oncologist at the Massachusetts General Hospital (MGH). His practice includes pancreatic and liver surgery operations. Patient information videos about his most commonly performed operations are included below: 

Dr. Qadan's leadership positions include: 

  • Complex General Surgical Oncology Fellowship Program Director at the MGH
  • Harvard Medical Student Advanced Surgical Clerkship Director
  • Pancreas Cyst Multidisciplinary Clinic Director
  • Partners Network Resident and Fellow Wellbeing Council Faculty Advisor

Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York and served as the educational coordinator during his fellowship.

Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the MGH in Boston.

Clinical Interests:

Treats:

Locations

Surgical Oncology Associates
55 Fruit Street
Boston, MA 02114-2696
617-643-5153
Fax: 617-724-3895

Medical Education

  • MD, University of Edinburgh
  • PhD, University of Louisville
  • Residency, Stanford University Medical Center
  • Fellowship, Memorial Sloan Kettering Cancer Center

American Board Certifications

  • Surgery, American Board of Surgery
  • Complex General Surgical Oncology, American Board of Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Qadan completed a doctoral (PhD) degree in the study of immunologic mechanisms that are important in the development of infection following surgery. He currently has a basic science laboratory effort and his scientific and translational research focuses on the tumor microenvironment in the treatment of pancreas cancer.

In addition, Dr. Qadan is interested in clinical outcomes health services research that focuses on methods to collect, analyze, and improve outcomes related to cancer surgery at the National level. His projects are presented at National conferences and have recently earned multiple prize awards over the last few months.

Dr. Qadan is an active clinical investigator in several high impact clinical trials at the Massachusetts General Hospital in the field of hepatobiliary and pancreatic surgery. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.

Dr. Qadan is actively involved in many National societies including the AHPBA, SSO, SSAT, ALF, and several others. He currently holds active leadership roles in several organizations and has over 80 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is also an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center. 

If you are interested in making a direct donation to Dr. Qadan's research, please proceed to the "Email Me" link to coordinate delivery of your generous gift.

Publications